U.S. Physical Therapy insider files Form 144 to sell 743 shares

Rhea-AI Filing Summary

U.S. Physical Therapy (USPH) insider Graham Reeve has filed a Form 144 to sell 743 shares of common stock. The proposed sale has an aggregate market value of $52,761.58 and is planned for 11/21/2025 on the NYSE through J.P. Morgan Securities LLC. Shares outstanding were 15,204,119, providing context for the size of the planned sale. The shares to be sold relate to equity compensation, as 1,948 common shares were acquired on 11/21/2025 through the vesting of restricted stock grants issued between 08/16/2021 and 02/24/2025 as payment for services. In the prior three months, Reeve sold 763 common shares on 08/21/2025 for gross proceeds of $64,832.11. The signer represents that they are not aware of undisclosed material adverse information about the company’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	743	52761.58	15204119	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/21/2025	Vesting of Restricted Stock Grants - Grants issued from 08/16/2021 through 02/24/2025)	U.S. Physical Therapy (Issuer)			1948	11/21/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Graham Reeve 8944 Rolling Acres Trail Fair Oaks Ranch TX 78015	Common	08/21/2025	763	64832.11

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the USPH Form 144 filing disclose about insider share sales?

The filing shows that Graham Reeve has notified of an intended sale of 743 USPH common shares with an aggregate market value of $52,761.58. The planned sale is to take place on 11/21/2025 on the NYSE through J.P. Morgan Securities LLC.

How large is the planned USPH insider sale compared to shares outstanding?

The notice states that the insider plans to sell 743 common shares. Shares outstanding were listed as 15,204,119, which helps illustrate the relative size of the proposed sale.

How were the USPH shares being sold under Form 144 acquired?

The shares relate to equity compensation. The filing reports that 1,948 common shares were acquired on 11/21/2025 through the vesting of restricted stock grants issued from 08/16/2021 through 02/24/2025, with the consideration described as services rendered.

What prior USPH stock sales by this insider are reported in the last three months?

The document lists a prior transaction where Graham Reeve sold 763 common shares on 08/21/2025 for gross proceeds of $64,832.11.

Which broker and exchange are involved in the planned USPH share sale?

The planned sale of 743 USPH common shares is to be executed through J.P. Morgan Securities LLC, with the securities listed for sale on the NYSE.

What representation does the insider make about information on U.S. Physical Therapy?

By signing the notice, the person selling the securities represents that they do not know any material adverse information about the current or prospective operations of U.S. Physical Therapy that has not been publicly disclosed.